Cassava Sciences Inc (NASDAQ: SAVA): Stock That Needs Special Handling
Currently, there are 42.24M common shares owned by the public and among those 41.77M shares have been available to trade. The company’s stock has a 5-day price change of -88.07% and -86.62% over the past three months. SAVA shares are trading -82.94% year to date (YTD), with the 12-month market performance down to -81.30% lower. […]
Cassava Sciences Inc (NASDAQ: SAVA) Is Getting Increasingly Hard To Ignore
Currently, there are 42.24M common shares owned by the public and among those 41.77M shares have been available to trade. The company’s stock has a 5-day price change of -84.63% and -85.09% over the past three months. SAVA shares are trading -80.92% year to date (YTD), with the 12-month market performance down to -79.88% lower. […]
Institutional Exposure To Cassava Sciences Inc (SAVA)
Cassava Sciences Inc (SAVA) concluded trading on Thursday at a closing price of $32.18, with 4.63 million shares of worth about $148.86 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 47.61% during that period and on November 21, 2024 the price saw a […]
Growth Story Still Intact For Cassava Sciences Inc (SAVA)
BlackRock Fund Advisors has recently announced that it has increased stake in Cassava Sciences Inc (NASDAQ:SAVA) by 3.50%. After grabbing 2.54 million shares, the institutional investor is now in possession of 86046.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 6.03% having worth around $52.95 million. Moreover, The […]
